United Therapeutics is set to take a big step forward in its plans to pursue advances in the field of organ transplantation thanks to a new partnership with the University of Maryland. The company has announced a $24 million research partnership that will help the school establish a center specializing in cardiac xenotransplantation research, the first of its kind in the US.
SUBSCRIBE
Biohealth Innovation
Founding Member of
